Two Sigma Securities’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

Two Sigma Securities’s Portfolio PBLA Stock Details PBLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-584	Closed	-$10.7K	–	3883
2023 Q4	$10.7K	Buy	+584	New	+$9.14K	﹤0.01%	2809
2023 Q2	–	Sell	-80	Closed	-$21.2K	–	3565
2023 Q1	$21.2K	Buy	80 +77	+2,567%	+$74.6K	﹤0.01%	2356
2022 Q4	$4.85K	Buy	+3	New	+$10.2K	﹤0.01%	2453

Two Sigma Securities's PBLA Position: Q1 2024 in Review

Two Sigma Securities sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q1 2024, closing a stake of 584 shares — an estimated $10.7K sold.

Two Sigma Securities first reported a position in PBLA in Q4 2022 and held it in 3 quarters. The position peaked at $21.2K in Q1 2023. 0 funds tracked by Wall St. Rank hold PBLA as of Q1 2024.

Two Sigma Securities reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Two Sigma Securities sold 584 Panbela Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $10.7K.
Two Sigma Securities first reported a position in Panbela Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Two Sigma Securities's Panbela Therapeutics, Inc. Common Stock position peaked at $21.2K in Q1 2023.
0 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.